Spanish for pulmonology clinic nurses: the patient who uses his rescue inhaler four times a day and does not know this is a problem, the patient who started smoking again and has not told the team, and the patient who stopped his COPD medication because of side effects and said nothing

Ramón Espinoza was sixty-eight years old, a retired construction foreman from Fontana. He had been diagnosed with COPD four years ago, after a spirometry at his annual physical had confirmed the breathlessness he had been attributing to age and the Inland Empire heat. His pulmonologist had prescribed a fluticasone/salmeterol combination inhaler — one inhalation twice daily — and had explained, briefly, that this was the controller. Ramón had also been given a salbutamol rescue inhaler for as-needed use.

He had tried the combination inhaler for about two months. He did not feel a difference. The rescue inhaler, on the other hand, always helped. Within fifteen minutes of using the blue inhaler, he could breathe again. He had stopped using the combination inhaler gradually — every other day, then twice a week, then not at all. The rescue inhaler canister in his shirt pocket was the medication he understood.

He came to his quarterly pulmonology follow-up. The nurse checked in his rescue inhaler canister at intake and noticed it was nearly empty. The prescription had been filled twenty-three days ago. She asked how often he was using it. Ramón said: “La uso bastante. Cuatro o cinco veces al día. Pero siempre me ayuda — con eso me alcanza para hacer mis cosas.”

Three pulmonology outpatient patterns that arrive in the quarterly visit without announcing themselves: Ramón, who has been using his rescue inhaler four to five times daily for three months and considers this a sign that the medication works, not that the disease is uncontrolled; Elena Vásquez, 61, retired seamstress from Fresno, COPD Stage 2, who quit smoking eight years ago after a thirty-pack-year history, restarted after her sister died in January, and has not told anyone on her care team; and Jorge Cisneros, 52, school custodian from Bakersfield, newly diagnosed COPD, who stopped his tiotropium five weeks ago because it made his mouth dry and made it hard to go to the bathroom, and who did not call the clinic because he did not believe the side effect rose to the level of a call.

The patient who uses his rescue inhaler four times a day and does not know this is a problem

The combination inhaler Ramón had stopped using was not inert during the two months he had taken it. He had not had any exacerbations during those months. He also had not had any in the eight months before diagnosis. He had no comparison point for what controlled meant.

What Ramón did have was a precise and repeated experience of the rescue inhaler working. He used it in the morning to start the day. He used it before walking to the mailbox. He used it before going up the stairs to the second floor. He used it if he woke up at night unable to sleep well. The pattern was so embedded in his routine that he did not consider any of these triggers a symptom of uncontrolled disease. He considered them normal features of having COPD.

The nurse said: “Quiero preguntarle algo sobre el inhalador que usa cuatro o cinco veces al día. Usted me dijo que siempre le ayuda. ¿Es verdad — al inhalador le funciona bien a usted?”

Ramón: “Sí. En minutos me pasa. Por eso lo uso.”

“Bien. Lo que le voy a explicar no es que el inhalador azul está mal — ese inhalador funciona y usted lo necesita. Lo que quiero que entienda es lo que significa usarlo cuatro veces al día, y por qué eso nos dice algo sobre cómo están los pulmones.”

Ramón: “¿Qué dice?”

“Hay dos tipos de inhaladores para el EPOC. El inhalador azul — el que usa cuando le falta el aire — abre los bronquios de inmediato. En quince minutos. Es como apagar un incendio. Eso es lo que siente usted. Pero no trata la inflamación que está detrás — solo abre el camino en el momento. El otro inhalador — el que le recetaron para todos los días, el que le cuesta sentir — no abre los bronquios al instante. Lo que hace es reducir la inflamación del pulmón con el tiempo, para que los ataques sean menos frecuentes y menos fuertes. El azul apaga el incendio. El otro evita que el incendio empiece.”

Ramón was quiet for a moment. “¿Por qué no siento que me ayuda si lo uso?”

“Porque el inhalador de todos los días no da alivio inmediato como el azul. No va a sentirlo trabajar en el momento. Lo que hace es trabajar por dentro, en las paredes de los bronquios, reduciendo la inflamación a lo largo de semanas. Eso significa que cuando funciona bien, usted no siente nada diferente en el momento — lo que siente es que necesita menos el inhalador azul. Eso es la señal de que está funcionando: que usted lo usa una vez al día en vez de cuatro. Por eso se toma todos los días aunque se sienta bien — especialmente cuando se siente bien, porque eso es cuando está protegiendo el pulmón.”

Ramón: “Pero si el azul funciona cada vez que lo uso, ¿para qué necesito los dos?”

The nurse had been waiting for this question. It was the correct question.

“Porque el inhalador azul, si se usa demasiado seguido, pierde fuerza con el tiempo — el cuerpo se acostumbra y necesita más. Y porque hay un umbral: cuando usted necesita el inhalador azul cuatro o cinco veces al día, eso nos dice que la enfermedad no está controlada. No significa que el medicamento no funcione — significa que los pulmones necesitan más ayuda de la que el inhalador azul solo puede dar. Las veces que lo usa al día no son normales para alguien con el tratamiento correcto. Son la señal de que el tratamiento no está completo.”

Ramón: “Antes lo tomaba y no sentía diferencia.”

“Dos meses no es suficiente para sentir la diferencia en cómo respira — eso puede tomar cuatro a seis semanas solo para que la inflamación empiece a bajar, y más tiempo para que note que necesita menos el azul. Lo que le propongo es esto: que empecemos con el inhalador de todos los días de nuevo, que lo use cada mañana a la misma hora, y que lleve un registro de cuántas veces usa el azul en la semana. En seis semanas revisamos. Si está usando el azul menos de dos veces a la semana, el tratamiento está funcionando. Si sigue en cuatro veces al día, revisamos el plan.”

The nurse wrote in the chart: “Patient using rescue bronchodilator 4–5 times daily x 3 months. Controller ICS/LABA discontinued by patient approximately 6 weeks after initial prescription — patient reported feeling no immediate benefit and defaulted to exclusive rescue inhaler use. Extended education provided on controller vs. rescue inhaler mechanism (anti-inflammatory vs. bronchodilator), the reason the controller does not produce a felt effect in the moment, and the clinical significance of daily rescue inhaler use as an indicator of uncontrolled disease. Patient verbalized the fire metaphor correctly on teach-back. Controller restarted. Patient will track rescue inhaler use this week and return in six weeks. Pulmonary rehab referral placed.”

At the six-week follow-up, Ramón reported using the rescue inhaler twice that week, down from thirty-five times the week before his last visit. He had completed four sessions of pulmonary rehab. He arrived at the clinic having walked from the parking structure without stopping at the stairwell landing.

He said: “Ahora entiendo por qué el médico me lo recetó. No lo sentía, así que pensé que no servía. Pero lo que servía era que yo no lo estaba tomando.”

The patient who started smoking again and has not told the team

Elena Vásquez had quit smoking eight years ago. She had been a pack-a-day smoker for thirty-one years, starting at seventeen in Fresno, where she grew up and where she had worked as a seamstress for a garment company until the plant closed. Her COPD had been diagnosed six years ago. She had two exacerbations in her first year post-diagnosis, then none for five years. She considered herself a former smoker who had COPD but had it managed.

Her sister had died in January. Lung cancer, diagnosed in August, dead in December. Elena had driven to Modesto every weekend in November and December. She had bought her first pack of cigarettes in eight years on the drive home after the funeral.

She had not thought about it as relapse. She had thought about it as January.

By April she was smoking five cigarettes a day. She had had two COPD exacerbations in four months — one requiring steroids by phone, one an urgent care visit. She arrived at her June follow-up carrying the same jacket she always wore to clinic. When the nurse leaned in to attach the pulse-ox probe, she noticed the faint but unmistakable smell of cigarette smoke. The impression of a soft pack was visible in the breast pocket.

The nurse paused. The instinct was to confront. She did not.

She said: “Antes de hablar de cómo han ido los pulmones, quiero preguntarle algo. ¿Ha habido algún cambio en el tabaco en los últimos meses — o en algo nuevo que esté usando para fumar o vapear? A veces pasan cosas en la vida que hacen difícil mantener algo que se había dejado.”

Elena looked at the floor. Then: “Lo dejé hace ocho años. Pero cuando murió mi hermana en enero… ya no pude. Empecé de nuevo. Son pocos al día, pero sí.”

The nurse said: “Lo que pasó con su hermana — eso es muy difícil. Lo siento mucho.” She waited. Then: “Lo que me está diciendo es importante y se lo agradezco. No está aquí para que le dé un regaño. Está aquí para que la ayude.”

Elena: “Siento que fallé. Ocho años.”

“El cerebro tiene receptores que responden a la nicotina. Cuando hay estrés severo — una pérdida como la que tusted vivió — esos receptores se activan con más fuerza. El cuerpo busca alivio donde sabe que lo ha encontrado antes. Eso no es falta de fuerza de voluntad. Ocho años son ocho años reales. Lo que pasó en enero fue un golpe que no podía haberse anticipado. La biología respondió como está diseñada para responder bajo ese nivel de dolor.”

Elena: “Son cinco cigarrillos al día. No son veinte.”

“Le voy a decir lo que sí sé sobre eso. El tipo de EPOC que usted tiene — con el daño que ya está en los bronquios — responde a la exposición al tabaco incluso en cantidades pequeñas. Los dos episodios que tuvo desde enero — los dos son consistentes con eso. No estoy diciendo que cinco cigarrillos sean iguales a veinte. Estoy diciendo que para los pulmones de usted, cinco cigarrillos activan la inflamación de una manera que ya no son los mismos pulmones que tenía a los veinte años.”

The nurse did not deliver a lecture. She had made the clinical connection. Now she moved to options.

“Hoy tengo tres cosas que puedo hacer por usted antes de que salga. La primera: puedo llamar a la farmacia para que le manden un parche de nicotina — eso reduce la urgencia sin que tenga que pasar por una semana sin nada. La segunda: hay una línea en español — la California Tobacco Helpline, 1-800-NO-BUTTS — que tiene consejeros entrenados en lo que usted está viviendo. No son un libro de texto. La tercera: en vez de verla en seis meses, la llamo en dos semanas. Solo para saber cómo va. Eso es todo. ¿Cuál de las tres le parece posible?”

Elena took the Quitline number. She declined the patch for now. She said she would call the line. The nurse made a note in the chart: “Patient disclosed smoking resumption since January (sister's death). Currently 5 cigarettes/day. Two COPD exacerbations since January (consistent with resumed tobacco exposure in the context of existing airway disease). Non-judgmental disclosure conversation: validated the bereavement, named the neurobiology of relapse. Patient not ready for NRT today. California Tobacco Helpline number provided. Two-week follow-up call scheduled. Pulmonary rehab referral discussed — patient open to intake if smoking is reduced.”

The nurse called in two weeks. Elena had called the Quitline. She was smoking two cigarettes a day, down from five. She said: “La señora que me atendió dijo que lo que me pasó en enero es muy común. No me lo esperaba — que hubiera una palabra para eso.”

She had her pulmonary rehab intake scheduled for the following Tuesday. At the two-month follow-up she was no longer smoking. She said it was not because of anything dramatic. She said: “Dejé porque ya no me ayudaba con lo de mi hermana — y sí me estaba ayudando a estar peor.”

The patient who stopped his COPD medication because of side effects he could not name

Jorge Cisneros was fifty-two years old, a school custodian from Bakersfield. He had been diagnosed with COPD, GOLD Stage 2, seven months ago after a spirometry ordered by his primary care doctor following two winters of worsening productive cough. He had never smoked. His COPD was likely occupational — cleaning product aerosolization, degreaser exposure, twelve years in a poorly ventilated facility. His pulmonologist had started him on tiotropium 18 mcg once daily via HandiHaler three months ago.

Jorge had taken the tiotropium every day for the first three weeks. Then he noticed his mouth was dry by mid-morning. Then he noticed it was harder to have a bowel movement — not impossible, but different. He looked up the medication online and read a list of side effects that included dry mouth, constipation, urinary retention, blurred vision, and rapid heartbeat. He stopped taking the tiotropium. He did not call the clinic because the side effects seemed mild — not an emergency. He planned to mention it at his next visit.

Five weeks later he arrived for his six-month pulmonology follow-up. The nurse collected his medication list. Tiotropium was on the list. She asked: “El Spiriva — el inhalador que le recetaron para todos los días — ¿lo ha estado tomando?”

Jorge: “La verdad, lo dejé hace como cinco semanas. Me hacía sentir raro.”

The nurse did not ask why he had not called. She asked what “raro” meant.

“¿Puede decirme qué quiere decir ‘raro’? A veces cuando un medicamento hace sentir raro puede ser algo en el pecho, en el corazón, en la vista, o puede ser otra cosa completamente diferente. ¿Qué notó usted?”

Jorge: “La boca muy seca. Y me costó ir al baño bien — el estómago como cerrado. También la orina tardaba más. No es nada grave pero no me gustaba cómo me sentía.”

The nurse performed the anticholinergic safety screen before anything else.

“Lo que me está diciendo me da información importante. Antes de explicarle qué es lo que pasó, quiero hacerle unas preguntas rápidas. ¿Hubo algo en el corazón — latidos rápidos o irregulares que no eran normales para usted? ¿O en los ojos — visión borrosa o dolor en el ojo? ¿O dificultad para orinar completamente — no solo que tardaba más, sino que salía muy poca orina aunque hiciera esfuerzo?”

Jorge: “No. El corazón normal. Los ojos bien. La orina salía, solo tardaba un poco más.”

The nurse noted this. The safety screen was negative. What Jorge had experienced was predictable and manageable.

“Lo que usted tuvo — la boca seca, el estreñimiento leve, la orina que tardaba un poco — son efectos que pasan con este medicamento porque bloquea ciertas señales nerviosas en el cuerpo, no solo en los pulmones. Esas señales controlan la salivación, el movimiento intestinal, y la vejiga. Cuando el medicamento las bloquea, la saliva se reduce, el intestino se vuelve más lento, y la vejiga necesita más tiempo para responder. Eso es lo que usted sintió. No es una señal de que el medicamento le está haciendo daño al cuerpo. Es un efecto conocido, y la mayoría de pacientes que lo tienen lo notan las primeras semanas y mejora.”

Jorge: “Pensé que iba a seguir así siempre.”

“Para la mayoría de pacientes no sigue igual. El cuerpo se adapta. Pero hay cosas que puede hacer para que sea más fácil. Para la boca seca: tome un vaso de agua antes de usar el inhalador. Después de usarlo, enjuaguese la boca y escúpalo. Puede también masticar chicle sin azúcar por veinte minutos. Para el estreñimiento: más fibra, más líquido, y no retrasar cuando el cuerpo le avise. Si usted hace esas cosas y sigue moléstando después de dos semanas, me llama y lo revisamos.”

Then the distinction the nurse wanted Jorge to have for the rest of his treatment.

“Hay dos listas de efectos con este medicamento. La primera son efectos que son molestos pero que mejoran con el tiempo y que se pueden manejar — boca seca, estreñimiento leve, orina que tarda. Usted tuvo esa lista. La segunda lista son efectos que necesitan una llamada el mismo día: latidos rápidos o irregulares, dolor de ojo o visión borrosa, o no poder orinar nada aunque esté haciendo esfuerzo. ¿Tiene el número de la clínica en el teléfono?”

Jorge: “Sí.”

“Bien. Si pasa algo de la segunda lista, me llama ese día. No espera a la próxima cita. Lo de la primera lista — puede escribirme un mensaje y lo revisamos, pero no es urgente. Lo que usted tuvo es de la primera lista. ¿Le parece que puede probar el medicamento de nuevo con estas cosas que le estoy diciendo?”

Jorge: “Sí. Si hay manera de manejarlo, lo pruebo.”

The nurse wrote: “Tiotropium discontinued by patient 5 weeks ago secondary to xerostomia, mild constipation, and slightly prolonged urinary stream. Patient did not call clinic — assessed side effects as subclinical and anticipated addressing at visit. Anticholinergic safety screen negative (no palpitations, no visual disturbance, no urinary retention). Education provided on anticholinergic mechanism, distinction between manageable effects (List 1) and stop-and-call effects (List 2). Xerostomia management: pre-dose water, post-dose oral rinse, sugar-free gum. Constipation management: fiber and fluid increase, prompt response to urge. Tiotropium restarted today. Patient to call in 2 weeks to report. Spirometry at today’s visit shows no improvement from baseline (consistent with 5-week medication gap).”

Jorge called in two weeks. The dry mouth was better. He was using water before the dose every morning and had added a glass of water at breakfast. He said: “La boca seca ya no me molesta. Me acostumbré.”

At his six-month follow-up, his FEV1 had improved eight percent from the baseline at diagnosis. His constipation had resolved. He had not had any exacerbations. He arrived and said, without being asked, that he wanted to know about the second list again — could the nurse send it to him in writing? She printed the anticholinergic safety screen in Spanish and gave it to him. He folded it and put it in his wallet.

Three questions for every pulmonology clinic visit with a Spanish-speaking patient

The three patterns above — Ramón, Elena, Jorge — share one feature: they were each invisible to the standard structured intake until a specific question opened them. Rescue inhaler overuse does not surface unless you ask for the count and check the canister. Smoking relapse does not surface unless the question names the life circumstances that make relapse predictable. Medication discontinuation does not surface unless the question names the assumption the patient made about the side effect threshold for a call.

Question 1: “¿Cuántas veces usó el inhalador azul — el de emergencia, el que usa cuando le falta el aire — esta última semana? ¿Tiene el frasco aquí para que lo revise?”

Ask before any other medication question. Ask to see the canister. Count the remaining doses and subtract from the fill date. The patient who reports “bastante” or “cuatro o cinco veces” without alarm is describing uncontrolled disease, not adequate self-management. The patient who says “casi no lo uso” but presents a canister that is three-quarters empty after two weeks may be underreporting or may have had a recent cluster you have not heard about. The canister is the data.

Question 2: “¿Ha habido algún cambio en el tabaco en los últimos meses — o en algo nuevo que esté usando para fumar o vapear? A veces pasan cosas en la vida que hacen difícil mantener algo que se había dejado.”

Ask at every visit, including visits with patients who quit years ago. The phrase “a veces pasan cosas en la vida” gives the patient permission to name the bereavement, the stress, the relapse, without framing it as failure. The patient who has been an ex-smoker for eight years and relapsed in January is not lying about the eight years. She is carrying something that was easier to carry before she was sitting in the clinic. The question that names life circumstances as a predictable context for relapse reduces the barrier to disclosure more than any other phrasing.

Question 3: “¿Hay algún medicamento del pulmón que haya dejado de tomar — o que haya tomado con menos frecuencia — porque le hacía sentir algo que no le gustaba? A veces los pacientes dejan un medicamento sin decírselo al equipo porque no creen que el efecto sea suficientemente importante para una llamada.”

The last sentence does the clinical work. It names the reasoning the patient used — accurately — without judgment. Jorge stopped his tiotropium because he made a reasonable assessment that dry mouth and mild constipation did not warrant a clinic call. That assessment was not wrong by the standards he had been given. He had not been given the two-list framework at the time of prescription. The question that names his assumption out loud gives him the opportunity to correct the record without feeling he made a mistake. And it gives the nurse the opportunity to correct the clinical record before six months of spirometry data is lost to a gap that was entirely preventable.

Frequently asked questions

How do I explain the difference between a controller and a rescue inhaler in Spanish?

The patient who has been using his albuterol rescue inhaler four times a day does not usually know the word “controller” means something different from “rescue.” In patient language, the distinction that works is a fire metaphor: “El inhalador azul abre los bronquios de inmediato — es como apagar un incendio. El otro inhalador, el de todos los días, no da alivio inmediato. Reduce la inflamación con el tiempo para que los incendios sean menos frecuentes y menos fuertes. El azul apaga el incendio. El otro evita que el incendio empiece.” Name the asymmetry directly: the rescue inhaler feels like it works because it produces a felt effect in minutes. The controller takes weeks and produces no felt effect in the moment. The signal that the controller is working is not something the patient feels — it is that the rescue inhaler use goes down. “Cuando el inhalador de todos los días está funcionando, usted lo nota en que necesita menos el azul.”

How do I ask a COPD patient in Spanish if they have started smoking again without making them feel judged?

Avoid “¿Está fumando?” as an opener — it asks about current behavior and invites a defensive “no.” Ask about change instead: “¿Ha habido algún cambio en el tabaco en los últimos meses?” Then add the life-context clause: “A veces pasan cosas en la vida que hacen difícil mantener algo que se había dejado.” After the disclosure, resist the impulse to evaluate the quantity (“but only five”) before naming what you know clinically: the connection between any resumed tobacco exposure and the clinical findings the patient is presenting with. Then move immediately to three options available that day. The patient who leaves with a patch prescription, a Quitline number, and a two-week follow-up call is more likely to reduce than the patient who leaves with a lecture and a pamphlet.

What do I say in Spanish when a COPD patient stopped his medication because of side effects and did not tell anyone?

Do not ask why he did not call. Ask what “raro” means: “¿Puede decirme qué quiere decir ‘raro’? ¿Algo en el pecho, en el corazón, en la vista, o puede ser otra cosa?” After naming the symptoms, perform the anticholinergic safety screen (“¿Hubo latidos rápidos, visión borrosa, o no poder orinar nada?”). Then explain the mechanism without framing the side effects as serious: “La boca seca y el estreñimiento leve son efectos conocidos de este medicamento — no son una señal de daño.” Give the two-list framework so the patient knows what requires a same-day call (palpitations, visual changes, urinary retention) versus what is manageable. Dry mouth: water before the dose, oral rinse after, sugar-free gum. Constipation: fiber, fluids, promptness. Then: “¿Le parece que puede probar el medicamento de nuevo con estas cosas?”

What are the Spanish terms for COPD and common pulmonology medication side effects?

COPD: “EPOC” (enfermedad pulmonar obstructiva crónica); patients say “la enfermedad de los pulmones” or “el enfisema.” Shortness of breath: “me falta el aire,” “no me alcanza el aire,” “me ahogo” (implies more severe sensation). Wheezing: “silbido en el pecho,” “le canta el pecho,” “el pecho suena.” Rescue inhaler: “el inhalador de emergencia,” “el inhalador azul.” Controller inhaler: “el inhalador de todos los días,” “el inhalador preventivo.” Dry mouth: “boca seca,” “me reseca la boca.” Constipation: “estreñimiento,” “está cerrado el estómago,” “no puedo ir al baño.” Exacerbation: “crisis de EPOC,” “ataque,” “cuando se pone peor.” ICS oral candidiasis: “hongos en la boca,” “manchas blancas en la lengua.” Vaping: “vapear,” “el vape,” “el cigarrillo electrónico.”

Three Spanish questions to ask at every pulmonology clinic visit with a Spanish-speaking patient?

(1) “¿Cuántas veces usó el inhalador azul — el de emergencia — esta última semana? ¿Tiene el frasco aquí para que lo revise?” — before any other medication question. Check the canister. Count doses remaining against the fill date. (2) “¿Ha habido algún cambio en el tabaco en los últimos meses? A veces pasan cosas en la vida que hacen difícil mantener algo que se había dejado.” — at every visit, including with patients who quit years ago. (3) “¿Hay algún medicamento del pulmón que haya dejado de tomar porque le hacía sentir algo que no le gustaba? A veces los pacientes dejan un medicamento sin decírselo al equipo porque no creen que el efecto sea suficientemente importante para una llamada.” — names the Jorge assumption directly and without blame.

Related reading: Respiratory emergency in Spanish: asthma, COPD exacerbation, and the patient who says “me falta el aire” · The brown-paper-bag medication review in Spanish: a 7-rule playbook from real shifts · Discharge instructions in Spanish: why the last 5 minutes of the ED visit are the most dangerous · Spanish for home health nurses: the patient who has been doing her own wound care, the patient whose medications went wrong after the hospital visit, and the patient who has not told her daughter what her diagnosis actually is · Spanish for cardiology clinic nurses · Spanish for nephrology clinic nurses · How to explain a new diagnosis in Spanish · Spanish for occupational health nurses · Practice these scenarios on ClinicaLingo · Download the free 50-phrase clinical-Spanish PDF